Table 1 Correlations between PKHD1L1 and the clinical characteristics of patients with lung adenocarcinoma.
Characteristics | Low expression of PKHD1L1 | High expression of PKHD1L1 | P value |
|---|---|---|---|
n | 269 | 270 | Â |
Pathologic T stage, n (%) | < 0.001 | ||
 T1 | 62 (11.6%) | 114 (21.3%) |  |
 T2 | 162 (30.2%) | 130 (24.3%) |  |
 T3 | 33 (6.2%) | 16 (3%) |  |
 T4 | 11 (2.1%) | 8 (1.5%) |  |
Pathologic N stage, n (%) | 0.001 | ||
 N0 | 158 (30.2%) | 192 (36.7%) |  |
 N1 | 60 (11.5%) | 37 (7.1%) |  |
 N2 | 47 (9%) | 27 (5.2%) |  |
 N3 | 0 (0%) | 2 (0.4%) |  |
Pathologic M stage, n (%) | 0.116 | ||
 M0 | 189 (48.5%) | 176 (45.1%) |  |
 M1 | 17 (4.4%) | 8 (2.1%) |  |
Pathologic stage, n (%) | 0.001 | ||
 Stage I | 126 (23.7%) | 170 (32%) |  |
 Stage II | 71 (13.4%) | 54 (10.2%) |  |
 Stage III | 52 (9.8%) | 32 (6%) |  |
 Stage IV | 17 (3.2%) | 9 (1.7%) |  |
Gender, n (%) | 0.577 | ||
 Female | 141 (26.2%) | 148 (27.5%) |  |
 Male | 128 (23.7%) | 122 (22.6%) |  |
Smoker, n (%) | 0.645 | ||
 No | 40 (7.6%) | 37 (7%) |  |
 Yes | 220 (41.9%) | 228 (43.4%) |  |
Race, n (%) | 0.077 | ||
 Asian | 7 (1.5%) | 1 (0.2%) |  |
 Black or African American | 25 (5.3%) | 30 (6.4%) |  |
 White | 196 (41.5%) | 213 (45.1%) |  |
Age, n (%) | 0.541 | ||
 ≤ 65 | 131 (25.2%) | 126 (24.2%) |  |
 > 65 | 127 (24.4%) | 136 (26.2%) |  |
OS event, n (%) | < 0.001 | ||
 Alive | 150 (27.8%) | 197 (36.5%) |  |
 Dead | 119 (22.1%) | 73 (13.5%) |  |
DSS event, n (%) | 0.012 | ||
 No | 176 (35%) | 207 (41.2%) |  |
 Yes | 71 (14.1%) | 49 (9.7%) |  |
